mpt 21 (somerfield hospital) limited Company Information
Company Number
05783492
Next Accounts
65 days late
Industry
Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
Shareholders
mpt uk holdings limited
Group Structure
View All
Contact
Registered Address
floor 6 61 curzon street, london, W1J 8PD
Website
-mpt 21 (somerfield hospital) limited Estimated Valuation
Pomanda estimates the enterprise value of MPT 21 (SOMERFIELD HOSPITAL) LIMITED at £0 based on a Turnover of £0 and 3.29x industry multiple (adjusted for size and gross margin).
mpt 21 (somerfield hospital) limited Estimated Valuation
Pomanda estimates the enterprise value of MPT 21 (SOMERFIELD HOSPITAL) LIMITED at £0 based on an EBITDA of £-28k and a 6.98x industry multiple (adjusted for size and gross margin).
mpt 21 (somerfield hospital) limited Estimated Valuation
Pomanda estimates the enterprise value of MPT 21 (SOMERFIELD HOSPITAL) LIMITED at £7.6m based on Net Assets of £4.8m and 1.58x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mpt 21 (somerfield Hospital) Limited Overview
Mpt 21 (somerfield Hospital) Limited is a live company located in london, W1J 8PD with a Companies House number of 05783492. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in April 2006, it's largest shareholder is mpt uk holdings limited with a 100% stake. Mpt 21 (somerfield Hospital) Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mpt 21 (somerfield Hospital) Limited Health Check
Pomanda's financial health check has awarded Mpt 21 (Somerfield Hospital) Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 2 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (1.3%)
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Employees
with 3 employees, this is below the industry average (4)
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.6%, this is a lower level of debt than the average (70.3%)
- - Mpt 21 (somerfield Hospital) Limited
- - Industry AVG
MPT 21 (SOMERFIELD HOSPITAL) LIMITED financials
Mpt 21 (Somerfield Hospital) Limited's latest turnover from December 2022 is 0 and the company has net assets of £4.8 million. According to their latest financial statements, Mpt 21 (Somerfield Hospital) Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | May 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 0 | 0 | 0 | 1,075,000 | 1,962,000 | 1,951,000 | 1,709,000 | 1,263,000 | 1,894,000 | 1,848,000 | 1,816,000 | 1,748,000 | 1,684,000 | 1,684,000 |
Other Income Or Grants | 0 | 0 | 0 | 0 | |||||||||||
Cost Of Sales | 0 | 0 | 0 | 0 | |||||||||||
Gross Profit | 0 | 0 | 0 | 0 | |||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | -3,467,000 | -13,656,000 | -3,356,000 | 696,000 | -1,557,000 | 1,327,000 | 1,213,000 | -2,205,000 | 1,256,000 | 1,215,000 | 1,222,000 | ||||
Interest Payable | 0 | 0 | 0 | 570,000 | 711,000 | 718,000 | 727,000 | 650,000 | 188,000 | 287,000 | 311,000 | 4,704,000 | 907,000 | 916,000 | 934,000 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
Pre-Tax Profit | -27,000 | -29,000 | -30,000 | 7,327,000 | -3,467,000 | -13,656,000 | -3,356,000 | 696,000 | -1,557,000 | -234,000 | 1,068,000 | -6,909,000 | 349,000 | 299,000 | 288,000 |
Tax | -1,000 | 0 | 0 | -2,000 | 44,000 | 505,000 | 807,000 | -194,000 | 90,000 | 212,000 | -496,000 | 445,000 | -219,000 | -213,000 | -210,000 |
Profit After Tax | -28,000 | -29,000 | -30,000 | 7,325,000 | -3,423,000 | -13,151,000 | -2,549,000 | 502,000 | -1,467,000 | -22,000 | 572,000 | -6,464,000 | 130,000 | 86,000 | 78,000 |
Dividends Paid | 85,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -113,000 | -29,000 | -30,000 | 7,325,000 | -3,423,000 | -13,151,000 | -2,549,000 | 502,000 | -1,467,000 | -22,000 | 572,000 | -6,464,000 | 130,000 | 86,000 | 78,000 |
Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Number Of Employees | 3 | ||||||||||||||
EBITDA* | -3,467,000 | -13,656,000 | -3,356,000 | 696,000 | -1,557,000 | 1,327,000 | 1,635,000 | -1,744,000 | 1,717,000 | 1,675,000 | 1,683,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | May 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 560,000 | 3,000,000 | 16,090,000 | 19,801,000 | 19,954,000 | 0 | 0 | 14,689,000 | 15,151,000 | 15,611,000 | 16,071,000 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 38,000 | 0 | 0 | 19,680,000 | 19,355,000 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 769,000 | 439,000 | 0 | 0 | 0 | 496,000 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 560,000 | 3,000,000 | 16,897,000 | 20,240,000 | 19,954,000 | 19,680,000 | 19,355,000 | 15,185,000 | 15,151,000 | 15,611,000 | 16,071,000 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 392,000 | 392,000 | 392,000 | 0 | 392,000 | 392,000 | 0 | 0 | 0 |
Group Debtors | 4,855,000 | 4,958,000 | 8,067,000 | 4,873,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,316,000 | 2,832,000 | 2,324,000 |
Misc Debtors | 0 | 0 | 4,000 | 3,230,000 | 1,000 | 13,000 | 2,000 | 2,000 | 2,000 | 604,000 | 0 | 19,000 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 4,855,000 | 4,958,000 | 8,071,000 | 8,103,000 | 1,000 | 13,000 | 394,000 | 394,000 | 394,000 | 604,000 | 392,000 | 411,000 | 3,316,000 | 2,832,000 | 2,324,000 |
total assets | 4,855,000 | 4,958,000 | 8,071,000 | 8,103,000 | 561,000 | 3,013,000 | 17,291,000 | 20,634,000 | 20,348,000 | 20,284,000 | 19,747,000 | 15,596,000 | 18,467,000 | 18,443,000 | 18,395,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 53,000 | 15,907,000 | 0 | 0 | 150,000 | 12,224,000 | 12,550,000 | 201,000 | 153,000 | 114,000 | 86,000 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 9,000 | 0 | 19,000 | 13,000 | 320,000 | 0 | 0 | 0 | 0 | 1,167,000 | 1,167,000 | 1,167,000 | 1,163,000 | 1,164,000 | 1,102,000 |
other short term finances | 0 | 0 | 0 | 0 | 225,000 | 438,000 | 478,000 | 380,000 | 391,000 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 18,000 | 17,000 | 18,000 | 26,000 | 121,000 | 625,000 | 563,000 | 563,000 | 480,000 | 414,000 | 368,000 | 321,000 | 421,000 | 412,000 | 426,000 |
total current liabilities | 27,000 | 17,000 | 37,000 | 39,000 | 719,000 | 16,970,000 | 1,041,000 | 943,000 | 1,021,000 | 13,805,000 | 14,085,000 | 1,689,000 | 1,737,000 | 1,690,000 | 1,614,000 |
loans | 0 | 0 | 0 | 0 | 16,730,000 | 626,000 | 17,127,000 | 17,212,000 | 17,811,000 | 0 | 0 | 13,094,000 | 13,297,000 | 13,450,000 | 13,564,000 |
hp & lease commitments | 0 | 0 | 0 | 0 | 1,118,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 589,000 | 589,000 | 589,000 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 555,000 | 1,362,000 | 1,169,000 | 4,288,000 | 3,774,000 | 4,585,000 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 17,848,000 | 626,000 | 17,682,000 | 18,574,000 | 18,980,000 | 4,288,000 | 3,774,000 | 17,679,000 | 13,886,000 | 14,039,000 | 14,153,000 |
total liabilities | 27,000 | 17,000 | 37,000 | 39,000 | 18,567,000 | 17,596,000 | 18,723,000 | 19,517,000 | 20,001,000 | 18,093,000 | 17,859,000 | 19,368,000 | 15,623,000 | 15,729,000 | 15,767,000 |
net assets | 4,828,000 | 4,941,000 | 8,034,000 | 8,064,000 | -18,006,000 | -14,583,000 | -1,432,000 | 1,117,000 | 347,000 | 2,191,000 | 1,888,000 | -3,772,000 | 2,844,000 | 2,714,000 | 2,628,000 |
total shareholders funds | 4,828,000 | 4,941,000 | 8,034,000 | 8,064,000 | -18,006,000 | -14,583,000 | -1,432,000 | 1,117,000 | 347,000 | 2,191,000 | 1,888,000 | -3,772,000 | 2,844,000 | 2,714,000 | 2,628,000 |
Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | May 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -3,467,000 | -13,656,000 | -3,356,000 | 696,000 | -1,557,000 | 1,327,000 | 1,213,000 | -2,205,000 | 1,256,000 | 1,215,000 | 1,222,000 | ||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 422,000 | 461,000 | 461,000 | 460,000 | 461,000 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -1,000 | 0 | 0 | -2,000 | 44,000 | 505,000 | 807,000 | -194,000 | 90,000 | 212,000 | -496,000 | 445,000 | -219,000 | -213,000 | -210,000 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -103,000 | -3,113,000 | 8,070,000 | 8,102,000 | -12,000 | -1,150,000 | 330,000 | 439,000 | -210,000 | 212,000 | -515,000 | -2,409,000 | 484,000 | 508,000 | 2,324,000 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 1,000 | -1,000 | -103,000 | -95,000 | -504,000 | 62,000 | 0 | 83,000 | 66,000 | 46,000 | 47,000 | -689,000 | 9,000 | -14,000 | 1,015,000 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -555,000 | -807,000 | 193,000 | -3,119,000 | 514,000 | -811,000 | 4,585,000 | 0 | 0 | 0 |
Cash flow from operations | -3,915,000 | -12,494,000 | -3,686,000 | -4,310,000 | 1,887,000 | 890,000 | 5,006,000 | 1,023,000 | 940,000 | 164,000 | |||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | -38,000 | 38,000 | 0 | -19,680,000 | 325,000 | 19,355,000 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | -53,000 | -53,000 | -15,854,000 | 15,907,000 | 0 | -150,000 | -12,074,000 | -326,000 | 12,349,000 | 48,000 | 39,000 | 28,000 | 86,000 |
Group/Directors Accounts | 9,000 | -19,000 | -301,000 | -307,000 | 320,000 | 0 | 0 | 0 | -1,167,000 | 0 | 0 | 4,000 | -1,000 | 62,000 | 1,102,000 |
Other Short Term Loans | 0 | 0 | -225,000 | -225,000 | -213,000 | -40,000 | 98,000 | -11,000 | 391,000 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | -16,730,000 | -16,730,000 | 16,104,000 | -16,501,000 | -85,000 | -599,000 | 17,811,000 | 0 | -13,094,000 | -203,000 | -153,000 | -114,000 | 13,564,000 |
Hire Purchase and Lease Commitments | 0 | 0 | -1,118,000 | -1,118,000 | 1,118,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | 0 | 0 | 0 | -570,000 | -711,000 | -718,000 | -727,000 | -650,000 | -187,000 | -286,000 | -310,000 | -4,704,000 | -907,000 | -916,000 | -934,000 |
cash flow from financing | 9,000 | -3,083,000 | 7,643,000 | -258,000 | 764,000 | -1,352,000 | -714,000 | -1,142,000 | 4,397,000 | -287,000 | 4,033,000 | -5,007,000 | -1,022,000 | -940,000 | 16,368,000 |
cash and cash equivalents | |||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
mpt 21 (somerfield hospital) limited Credit Report and Business Information
Mpt 21 (somerfield Hospital) Limited Competitor Analysis
Perform a competitor analysis for mpt 21 (somerfield hospital) limited by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other established companies, companies in W1J area or any other competitors across 12 key performance metrics.
mpt 21 (somerfield hospital) limited Ownership
MPT 21 (SOMERFIELD HOSPITAL) LIMITED group structure
Mpt 21 (Somerfield Hospital) Limited has no subsidiary companies.
Ultimate parent company
1 parent
MPT 21 (SOMERFIELD HOSPITAL) LIMITED
05783492
mpt 21 (somerfield hospital) limited directors
Mpt 21 (Somerfield Hospital) Limited currently has 5 directors. The longest serving directors include Mr James Hanna (Jan 2020) and Ms Katie Williams (Dec 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr James Hanna | United Kingdom | 52 years | Jan 2020 | - | Director |
Ms Katie Williams | United Kingdom | 37 years | Dec 2021 | - | Director |
Ms Stephanie Hamner | United Kingdom | 32 years | Dec 2021 | - | Director |
Mr Conor Odonnell | United Kingdom | 34 years | Jul 2024 | - | Director |
Mr Charles Salmon | United Kingdom | 33 years | Jul 2024 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-28k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
4.8m
-0.02%
total assets
4.9m
-0.02%
cash
0
0%
net assets
Total assets minus all liabilities
mpt 21 (somerfield hospital) limited company details
company number
05783492
Type
Private limited with Share Capital
industry
68209 - Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
incorporation date
April 2006
age
18
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2022
previous names
ghg 21 (somerfield hospital) limited (February 2020)
pantomime propco 21 limited (November 2006)
accountant
-
auditor
GRANT THORNTON UK LLP
address
floor 6 61 curzon street, london, W1J 8PD
Bank
-
Legal Advisor
-
mpt 21 (somerfield hospital) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 13 charges/mortgages relating to mpt 21 (somerfield hospital) limited. Currently there are 0 open charges and 13 have been satisfied in the past.
mpt 21 (somerfield hospital) limited Companies House Filings - See Documents
date | description | view/download |
---|